Affiliation:
1. Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abstract
For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and (especially) treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.
Publisher
American Association for the Advancement of Science (AAAS)
Reference44 articles.
1. www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2006_Presentation.asp.
2. J. Pearce, New York Times, 16 March 2006, p. A25.
3. J. H. Burchenal, M. L. Murphy, C. T. Tan, Pediatrics18, 643 (1956).
4. www.beyonddiscovery.org/content/view.article.asp?a=285.
5. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Cited by
271 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献